Abstract. Adenosine enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. We found that adenosine increases NGF-induced phosphorylation of extracellular signalregulated kinase (ERK), but decreases the duration of phosphorylation of p38 mitogen-activated protein (MAP) kinase. Therefore, we further examined the involvement of protein phosphatase in these effects of adenosine. FK506, a specific calcineurin inhibitor, inhibited the enhancing effect of adenosine on the NGF-induced neurite outgrowth and increased the duration of p38 MAP kinase phosphorylation without affecting ERK phosphorylation. These results suggest that adenosine decreases the duration of p38 MAP kinase via calcineurin activation, which contributes to the enhancement of NGF-induced neurite outgrowth.
Introduction
Nerve growth factor (NGF)-induced neuronal differentiation of the phaeochromocytoma cell (PC)-12 cell line is well-studied (1, 2) . NGF-induced activation of mitogen-activated protein (MAP) kinase pathways is critical for neuronal differentiation of PC12 cells (3, 4) . Previously, Huffaker et al. (5) demonstrated that low concentrations of adenosine (10 -50 mM) enhance NGF-induced neurite outgrowth of PC12 cells. Moreover, adenosine enhances NGF-induced activation of extracellular signal-regulated kinase (ERK) via adenosine-A 2A -receptor-mediated increases in cyclic adenosine monophosphate (cAMP) (6) . These studies indicate a synergistic coupling between adenosine and NGF signaling pathways to potentiate neurite outgrowth in PC12 cells. The present study investigated the effect of adenosine on NGF-induced activation of p38 MAP kinase, because the p38 MAP kinase pathway is also critically involved in NGF-induced neuronal differentiation in PC12 cells (4) . We demonstrated that adenosine decreases the duration of NGF-induced activation of p38 MAP kinase via calcineurin activation, which contributes to the enhancement of NGF-induced neurite outgrowth.
Materials and Methods

Materials
PC12 cells were obtained from the Riken Cell Bank (Tsukuba). Nerve growth factor (NGF2.5S) and Dulbecco's Modified Eagle Medium (DMEM) was obtained from Gibco BRL (Rockville, MD, USA). Calyculin A and okadaic acid were obtained from Wako Pure Chemical Co. (Osaka). Adenosine, dibutyryl adenosine-3',5'-cyclic-monophosphate (dbcAMP), 8-(3-chlorostyryl)caffeine (CSC), SQ22536 (9-(tetrahydro-2-furanyl)-9H-purine-6-amine), Rp-cAMPS, cyclosporin A (CsA), and SB203580 (4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole) were obtained from Sigma Chemical Co. (St. Louis, MO, USA). FK506 was obtained from Calbiochem (San Diego, CA, USA). Anti-phospho-ERK1 / ERK2 antibody and horseradish peroxidase conjugated donkey anti-rabbit IgG were obtained from Promega (Madison, WI, USA). Anti-phospho-p38MAP kinase was obtained from New England Biolabs (Beverly, MA, USA). All other chemicals were of analytical grade and were obtained from Sigma Chemical Co. or Wako Pure Chemical Co.
Cell culture
PC12 cells were maintained in DMEM containing 5% fetal bovine serum (FBS; Hyclone, Logan, UT, USA), 5% horse serum (ICN, Costa Mesa, CA, USA), penicillin G sodium (1´10 5 U/ L), and streptomycin sulfate (1´10 5 mg / L) in 5% CO 2 at 37°C. For the neuronal differentiation experiments, PC12 cells were seeded on 35-mm culture dishes (2´10 4 cells). NGF (50 ng / ml), adenosine, and dbcAMP were added 24 h after seeding; and calyculin A, okadaic acid, and FK506 were added 30 min before addition of NGF. The cells were cultured in the presence of varying concentrations of the inhibitors. Calyculin A and okadaic acid were removed by washing once with phosphate-buffered saline (PBS) 3 h after adding the inhibitors and then by changing the culture medium containing NGF. FK506 was maintained in the medium until the cells were examined. The number of cells possessing neurites greater than the diameter of a cell body was assessed 48 h after adding NGF.
Western blot analysis
The cells were solubilized in 100 ml sample buffer containing 2% sodium dodecyl sulfate (SDS), 10% glycerol, 50 mM dithiothreitol, 0.1% bromophenol blue, and 62.5 mM Tris-HCl (pH 6.8) after washing once with PBS. The solubilized materials were subjected to SDS-polyacrylamide gel electrophoresis (5 -20% gradient polyacrylamide) after boiling for 3 min and transferred onto nitrocellulose membranes at 4°C in 25 mM Tris-HCl (pH 8.4), 192 mM glycine, 20% methanol, and 0.025% SDS. After blocking, the blots were probed with anti-phospho-ERK or anti-phosphop38 MAP kinase antibody, followed by goat anti-rabbit IgG conjugated to horseradish peroxidase. The immunoreactive proteins were visualized following the reaction with 3,3'-diaminobenzidine tetrahydrochloride.
Results
We first examined whether adenosine enhances NGFinduced neurite outgrowth in PC12 cells. Adenosine alone did not have an effect on the cells. On the other hand, treatment of the cells with adenosine in the presence of NGF enhanced NGF-induced neurite outgrowth in a dose-dependent manner (Fig. 1A) . This enhancing effect of adenosine was completely blocked by CSC, a specific adenosine A 2A receptor antagonist (Fig. 1C) . We also examined the effect of SQ22536, a specific adenylate cyclase inhibitor, and Rp-cAMPS, a specific protein kinase A (PKA) inhibitor, on the adenosine effect because activation of adenosine A 2A receptors leads to increases in cAMP via activation of adenylate cyclase in PC12 cells (7) . Both SQ22536 and Rp-cAMPS significantly inhibited the adenosine effect (Fig. 1C) . These results suggest that adenosine enhances the NGF-induced neurite outgrowth via activation of the cAMP-PKA pathway after specific binding to the adenosine A 2A receptor. To obtain more direct evidence that activation of the cAMP-PKA pathway is involved in the adenosine effect, the cells were treated with varying concentrations of dbcAMP, a membranepermeable cAMP analogue, in the presence or absence of NGF. As shown in Fig. 1B , treatment of the cells with dbcAMP enhanced NGF-induced neurite outgrowth in a dose-dependent manner. Only a high concentration of dbcAMP (100 mM) slightly but significantly promoted neurite outgrowth even in the absence of NGF. These results also suggest that activation of the cAMP-PKA pathway is critical for the enhancing effect of adenosine on NGF-induced neurite outgrowth.
Activation of the ERK and p38 MAP kinase pathways is required for NGF-induced neuronal differentiation in PC12 cells (3, 4) . Therefore, we examined the effect of adenosine on the NGF-induced activation of ERK and p38 MAP kinase. Activation of ERK and p38 MAP kinase was assessed by measuring changes in immunoreactivity to phosphorylation-dependent antibodies. ERK and p38 MAP kinase were transiently phosphorylated soon after NGF-treatment ( Involvement of protein phosphatases in the regulation of many protein kinases has been suggested in many studies (10) . We, therefore, examined the involvement of protein phosphatase (PP) on the effects of adenosine.
Calyculin A, an inhibitor of both type 1 (PP-1) and type 2A (PP-2A) protein phosphatase, inhibited NGFinduced neurite outgrowth without any effect on the phosphorylation levels of MAP kinases (Fig. 3) . The same results were obtained by the treatment with another phosphatase inhibitor, okadaic acid, the effect of which is less potent against PP-1 than PP-2A (Fig. 3) . These findings are similar to those of Chiou and Westhead (11) and Reber and Bouron (12) and suggest that PP-1 and / or PP-2A is involved in NGF-induced neurite outgrowth downstream of the signaling pathway after MAP kinase activation. On the other hand, FK506, a specific inhibitor of calcineurin (type 2B protein phosphatase, PP-2B) (13) , inhibited the enhancing effect of adenosine on NGF-induced neurite outgrowth, but had no effect on the NGF-induced effect (Fig. 4Aa) . The same results were obtained by the treatment with another calcineurin inhibitor CsA (Fig. 4Ab) . When the cells were treated with FK506 in the presence of db-cAMP, FK506 inhibited the enhancing effect of dbcAMP on NGF-induced neurite outgrowth in a dosedependent manner (Fig. 4B) . Thus, FK506 blocked the enhancing effects of both adenosine and dbcAMP on the NGF-induced neurite outgrowth. Under the same conditions, FK506, but not calyculin A and okadaic acid, recovered the duration of p38 MAP kinase phosphorylation that was decreased by adenosine to that of NGF-treatment alone (Fig. 5B) . Neither the levels nor the duration of the ERK phosphorylation was affected by FK506 (Fig. 5A ).
To examine whether the decreased duration of p38 MAP kinase activation directly affects NGF-induced neurite outgrowth, we treated the cells with SB203580, a specific p38 MAP kinase inhibitor, for 3 h between 90 and 270 min following the addition of NGF. This short treatment period with SB203580 significantly enhanced NGF-induced neurite outgrowth (Fig. 6A) . In contrast, pretreatment of the cells with SB203580 before the addition of NGF significantly inhibited NGF-induced neurite outgrowth without affecting ERK phosphorylation (Fig. 6B) . Thus, p38 MAP kinase activation is necessary for NGF-induced neurite outgrowth, and the duration time of p38 MAP kinase activation importantly affects NGF-induced neurite outgrowth. These results suggest that adenosine activates calcineurin via activation of the cAMP-PKA pathway leading to a short duration of p38 MAP kinase activation, which results in enhanced NGF-induced neurite outgrowth.
Discussion
The present study demonstrated that the duration of p38 MAP kinase activation importantly influences NGF-induced neuronal differentiation of PC12 cells. Also, adenosine activates calcineurin (PP-2B) to decrease the duration-time, which results in the enhancement of the NGF-induced neurite outgrowth.
Treatment of PC12 cells with NGF induces activation of both ERK and p38 MAP kinase and leads to growth arrest and neuronal differentiation (3, 4) . Although epidermal growth factor (EGF) induces activation of both ERK and p38 MAP kinase, EGF stimulates the proliferation of cells instead of neuronal differentiation (2, 9) . These studies also indicate that there are marked differences in the kinetics of ERK and p38 MAP kinase activation between EGF and NGF treatments: EGFinduced activation of those MAP kinases is more transient than NGF-induced activation (4, 9) . Therefore, such different cellular responses between NGF and EGF might derive from the different duration of ERK and p38 MAP kinase activation induced by those growth factors. Indeed, Traverse et al. (14) demonstrated that overexpression of EGF receptors in PC12 cells induces a sustained activation of MAP kinases and leads to neuronal differentiation in response to EGF. Furthermore, Morooka and Nishida (4) demonstrated that sustained activation of p38 MAP kinase in combination with EGF treatment induces neurite outgrowth. In the present study, a short treatment with SB203580 decreased the duration of p38 MAP kinase activation and significantly enhanced NGF-induced neurite outgrowth (Fig. 6A) . These results suggest that not only the extent but also the duration of both ERK and p38 MAP kinase activation is important for determining the cellular response.
Transient activation of p38 MAP kinase is critical for both growth factor-mediated and integrin-mediated neurite outgrowth (4, 15, 16) . p38 MAP kinase, however, is also implicated in the mediation of apoptosis of four separate experiments. The phosphorylation levels of ERK and p38 MAP kinase (C) after treatments of cells with 50 ng/ml NGF (a), 50 ng/ml NGF plus 500 pM calyculin A (b), or 50 ng/ml NGF plus 100 nM okadaic acid (c) for the indicated times. For treatments with calyculin A or okadaic acid, the phosphatase inhibitors were added to the cells 30 min before addition of NGF. The phosphorylation of ERK and p38 MAP kinase was determined by immunoblotting with anti-phospho ERK antibody and anti-phospho p38 MAP kinase antibody, respectively. **P<0.01, vs NGF.
in PC12 cells besides NGF-induced neuronal differentiation (17 -19) . Indeed, NGF withdrawal from PC12 cells leads to sustained activation of p38 MAP kinase and then results in apoptosis of the cells (17, 18) . Thus, p38 MAP kinase is activated not only after NGF addition to but also after NGF withdrawal from the cells and regulates the two different signal pathways in PC12 cells. On the other hand, ERK is activated after NGF treatment, whereas NGF withdrawal results in a reduction in ERK activity in PC12 cells (17) . Direct and selective activation of the ERK pathway not only leads to stimulation of neurite outgrowth but also prevents apoptosis and promotes the survival of PC12 cells (17) . These reports suggest that simultaneous activation of p38 MAP kinase together with activation of ERK leads to neuronal differentiation, but that sole sustained activation of p38 MAP kinase might result in induction of apoptosis. Indeed, transient activation of p38 MAP kinase is required for NGF-induced neuronal differentiation in PC12 cells, but its activation occurs simultaneously with ERK activation ((4) and also Fig. 2 ). In the present study, we found that the duration of p38 MAP kinase activation is longer than that of ERK activation (Fig. 2) . When the duration of p38 MAP kinase activation was brought to shorter period by treatment with adenosine ( Fig. 2) and / or by a short treatment with SB203580 (Fig. 6A) , NGF-induced neurite outgrowth was enhanced. Thus, NGF-induced neurite outgrowth can be stimulated more efficiently when the duration of p38 MAP kinase activation is shorter than that of ERK activation. On the other hand, a longer duration of p38 MAP kinase activation than that of ERK activation tends to lead to suppression of NGF-induced neurite outgrowth, which might be partly due to apoptosis signaling pathways activated after p38 MAP kinase activation, because NGF-induced increase in ERK activity, which prevents apoptosis and promotes the survival, will have been already reduced to the basal level at a later stage of p38 MAP kinase activation. Both FK506 and CsA prevented only the enhancing effect of adenosine on the NGF-induced neurite outgrowth but not the effect of NGF alone (Fig. 4A) . Under the same conditions, FK506 recovered the duration of p38 MAP kinase phosphorylation that had been reduced by adenosine-treatment to that of NGF-treatment (Fig. 5B) . These results suggest that adenosine activates calcineurin, which can dephosphorylate the active form of p38 MAP kinase and shift the equilibrium state between phosphorylation and dephosphorylation to favor that of dephosphorylation, resulting in a decreased duration of p38 MAP kinase phosphorylation. The present study suggests that the decreased duration of p38 MAP kinase via adenosine-induced activation of calcineurin contributes to the enhancing effect of adenosine on NGF-induced neurite outgrowth. The mechanism by which adenosine activates calcineurin, however, remains unknown. Calcineurin is a Ca
2+
-and calmodulin-dependent protein phosphatase (20) . Treatment of PC12 cells with NGF increases inositol phosphates (21) , which results in a transient increase in intracellular Ca 2+ levels. Therefore, the NGF-induced transient increase in intracellular Ca 2+ levels might be required for calcineurin activation. The present study, however, demonstrated that the enhancing effect of adenosine on NGF-induced neurite outgrowth, but not the effect of NGF alone, is blocked by Rp-cAMPS, FK506, and CsA, suggesting that adenosine-induced PKA activation is involved in calcineurin activation. These results suggest that both the NGF-induced increase in intracellular Ca 2+ and adenosine-induced PKA activation might be required for calcineurin activation to regulate p38 MAP kinase phosphorylation in PC12 cells.
